1. Home
  2. AMRX vs CACC Comparison

AMRX vs CACC Comparison

Compare AMRX & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$18.05

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$618.86

Market Cap

6.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
CACC
Founded
2002
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.5B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
AMRX
CACC
Price
$18.05
$618.86
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$15.60
$505.00
AVG Volume (30 Days)
2.1M
177.8K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
83.00
EPS
0.19
12.40
Revenue
N/A
$2,317,200,000.00
Revenue This Year
$4.48
$91.73
Revenue Next Year
$7.13
$3.58
P/E Ratio
$92.18
$49.66
Revenue Growth
N/A
7.16
52 Week Low
$7.67
$401.90
52 Week High
$18.39
$668.86

Technical Indicators

Market Signals
Indicator
AMRX
CACC
Relative Strength Index (RSI) 67.85 52.68
Support Level $12.46 $529.10
Resistance Level N/A $668.86
Average True Range (ATR) 0.59 21.39
MACD -0.05 -4.84
Stochastic Oscillator 80.15 25.98

Price Performance

Historical Comparison
AMRX
CACC

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

Share on Social Networks: